Both in Pharmaceuticals
Stoke Therapeutics vs SELLAS Life Sciences Group
Over the past year STOK returned +8.3% and SLS returned +450.6%; their daily moves had a correlation of 0.23.
STOK +8.3% SLS +450.6%Growth of $1, one year, split-adjusted
| Metric | STOK | SLS |
|---|---|---|
| Price | $27.45 | $9.14 |
| Market cap | $1.77B | $1.85B |
| Today | +1.70% | +3.04% |
| 1 month | +12.6% | −19.4% |
| 6 months | −17.5% | +77.5% |
| Year to date | −13.5% | +142.4% |
| 1 year | +5.2% | +410.6% |
| Revenue growth (YoY) | +5.9% | — |
| Gross margin | 100.0% | — |
| Net margin | −654.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 62.8× | — |
| Net cash | $319.2M | $138.3M |
| Dividend yield | — | — |
| Volatility (60d) | 47.9% | 97.0% |
| Short % of float | 18.9% | 27.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).